Your browser doesn't support javascript.
loading
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
Di Bartolomeo, Maria; Niger, Monica; Morano, Federica; Corallo, Salvatore; Antista, Maria; Tamberi, Stefano; Lonardi, Sara; Di Donato, Samantha; Berardi, Rossana; Scartozzi, Mario; Cardellino, Giovanni Gerardo; Di Costanzo, Francesco; Rimassa, Lorenza; Luporini, Alberto Gianluigi; Longarini, Raffaella; Zaniboni, Alberto; Bertolini, Alessandro; Tomasello, Gianluca; Pinotti, Graziella; Scagliotti, Giorgio; Tortora, Giampaolo; Bonetti, Andrea; Spallanzani, Andrea; Frassineti, Giovanni Luca; Tassinari, Davide; Giuliani, Francesco; Cinieri, Saverio; Maiello, Evaristo; Verusio, Claudio; Bracarda, Sergio; Catalano, Vincenzo; Basso, Michele; Ciuffreda, Libero; De Vita, Ferdinando; Parra, Hector Soto; Fornaro, Lorenzo; Caporale, Marta; de Braud, Filippo; Pietrantonio, Filippo.
Afiliación
  • Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy. maria.dibartolomeo@istitutotumori.mi.it.
  • Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • Corallo S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • Antista M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • Tamberi S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Ravenna Viale Randi, 5, 48121, Ravenna, Italy.
  • Lonardi S; Department of Medical Oncology, IOV Istituto Oncologico Veneto, Via Gattamelata, 64, 35128, Padova, PD, Italy.
  • Di Donato S; Sandro Pitigliani Medical Oncology Department, Nuovo Ospedale di Prato, Via Suor Niccolina Infermiera, 20, 59100, Prato, Italy.
  • Berardi R; Department of Medical Oncology, AOU Ospedali Riuniti Di Ancona, via Corridoni, 11, 60123, Ancona, Italy.
  • Scartozzi M; Department of Medical Oncology, AOU Cagliari, Via Ospedale, 54, 09124, Cagliari, Italy.
  • Cardellino GG; Department of Medical Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330 - 33100, piazzale Santa Maria della misericordia 15, 33100, Udine, Udine, Italy.
  • Di Costanzo F; Department of Medical Oncology, AOU Careggi di Firenze, Largo Brambilla, 3, 50134, Florence, Italy.
  • Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Alessandro Manzoni, 56, 20089, Rozzano, Milan, Italy.
  • Luporini AG; Department of Medical Oncology, IRCCS Policlinico San Donato, Piazza Edmondo Malan, 2, 20097, San Donato Milanese, MI, Italy.
  • Longarini R; Department of Medical Oncology, Ospedale San Gerardo, Via G. B. Pergolesi, 33, 20900, Monza, Italy.
  • Zaniboni A; Department of Medical Oncology, Fondazione Poliambulanza, Via Leonida Bissolati, 57, 25124, Brescia, Italy.
  • Bertolini A; Department of Medical Oncology, ASST della Valtellina e dell'Alto Lario, Via Stelvio, 25, 23100, Sondrio, Italy.
  • Tomasello G; Department of Medical Oncology, Ospedale di Cremona, Viale Concordia, 1, 26100, Cremona, Italy.
  • Pinotti G; Department of Medical Oncology, Ospedale di Circolo e Fondazione Macchi, Viale Luigi Borri, 57, 21100, Varese, Italy.
  • Scagliotti G; Department of Medical Oncology, AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, Torino, Italy.
  • Tortora G; Department of Medical Oncology, AOUI Verona Ospedale Policlinico 'Giambattista Rossi' di Borgo Roma, Piazzale L.A. Scuro, 10, 37134, Verona, VR, Italy.
  • Bonetti A; Department of Medical Oncology, Ospedale Mater Salutis, Via Carlo Gianella, 1, 37045 Legnago, Verona, Italy.
  • Spallanzani A; Department of Medical Oncology, AOU di Modena, Via Emilia Est, 583-585, 41122, Modena, MO, Italy.
  • Frassineti GL; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, via P. Maroncelli, 40, 47014, Meldola, Italy.
  • Tassinari D; Department of Medical Oncology, Ospedale degli infermi di Rimini, Viale L. Settembrini, 2, 47923, Rimini, Italy.
  • Giuliani F; Department of Medical Oncology, I.R.C.C.S. Istituto Tumori Bari, Viale Orazio Flacco, 65, 70124, Bari, Italy.
  • Cinieri S; Department of Medical Oncology, Ospedale A. Perrino di Brindisi, Strada Statale 7 per Mesagne, 72100, Brindisi, Italy.
  • Maiello E; Department of Medical Oncology, Casa Sollievo della Sofferenza, Viale Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy.
  • Verusio C; Department of Medical Oncology, ASST Valle Olona, PO Saronno Piazzale Borella 1, 21047, Saronno, Varese, Italy.
  • Bracarda S; Department of Medical Oncology, Ospedale San Donato, Azienda USL Toscana Sudest Via Pietro Nenni, 20/22, 52100, Arezzo, Italy.
  • Catalano V; Department of Medical Oncology, Azienda Ospedaliera "Ospedali Riuniti Marche Nord", Piazzale Cinelli, 4, 61121, Pesaro, Italy.
  • Basso M; Department of Medical Oncology, Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli, 8, 00168, Rome, Italy.
  • Ciuffreda L; Department of Medical Oncology, A.O.U. Citta della Salute e della Scienza di Torino, H Molinette, corso Bramante, 88, 10126, Torino, Italy.
  • De Vita F; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'Luigi Vanvitelli' - School of Medicine, Via S.Pansini, 5, 80131, Naples, Italy.
  • Parra HS; Department of Medical Oncology, P.O. G. Rodolico, Via Plebiscito, 628, Catania, Italy.
  • Fornaro L; Department of Medical Oncology, AOU Pisana, Polo Oncologico - Osp. S. Chiara, via Roma 67, 56100, Pisa, Italy.
  • Caporale M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1, 20133, Milan, Italy.
  • Pietrantonio F; Department of Hematology-Oncology, University Milan, Milan, Italy.
BMC Cancer ; 19(1): 283, 2019 Mar 29.
Article en En | MEDLINE | ID: mdl-30922323
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Unión Esofagogástrica / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Unión Esofagogástrica / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Italia